Generelt Patienterne skal informeres om, at det ikke er påvist, at Sebivo reducerer risikoen for overførsel af HBV til andre ved seksuel kontakt eller blodkontaminering.
General Patients should be advised that treatment with Sebivo has not been shown to reduce the risk of transmission of HBV to others through sexual contact or blood contamination.